SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001750019-19-000036
Filing Date
2019-05-13
Accepted
2019-05-13 16:21:37
Documents
59
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcrr10q03312019.htm   iXBRL 10-Q 1703386
2 EXHIBIT 10.1 a101optionplanamendmen.htm EX-10.1 6308
3 EXHIBIT 31.1 a311certificationofpri.htm EX-31.1 10326
4 EXHIBIT 31.2 a312certificationofpri.htm EX-31.2 10339
5 EXHIBIT 32.1 a321certifcationsofpri.htm EX-32.1 8450
11 tcr2logohires.jpg GRAPHIC 167882
  Complete submission text file 0001750019-19-000036.txt   6586454

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrr-20190331.xsd EX-101.SCH 36933
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrr-20190331_cal.xml EX-101.CAL 63629
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrr-20190331_def.xml EX-101.DEF 208135
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrr-20190331_lab.xml EX-101.LAB 523982
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrr-20190331_pre.xml EX-101.PRE 303129
12 EXTRACTED XBRL INSTANCE DOCUMENT tcrr10q03312019_htm.xml XML 925262
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38811 | Film No.: 19818648
SIC: 2836 Biological Products, (No Diagnostic Substances)